SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-144030
Filing Date
2023-05-15
Accepted
2023-05-15 06:07:00
Documents
14
Period of Report
2023-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d420466d8k.htm   iXBRL 8-K 35890
2 EX-99.1 d420466dex991.htm EX-99.1 59601
6 GRAPHIC g420466g91r76.jpg GRAPHIC 3784
  Complete submission text file 0001193125-23-144030.txt   228909

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bioc-20230510.xsd EX-101.SCH 2851
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bioc-20230510_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bioc-20230510_pre.xml EX-101.PRE 10813
8 EXTRACTED XBRL INSTANCE DOCUMENT d420466d8k_htm.xml XML 3266
Mailing Address 9955 MESA RIM ROAD SAN DIEGO CA 92121
Business Address 9955 MESA RIM ROAD SAN DIEGO CA 92121 858-320-8200
BIOCEPT INC (Filer) CIK: 0001044378 (see all company filings)

IRS No.: 800943522 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36284 | Film No.: 23918120
SIC: 8071 Services-Medical Laboratories